Michigan Attorney General says GlaxoSmithKline underpaid the rebates it owed for drugs paid through the state’s Medicaid program.
Ann Arbor-based NanoBio Corp. Wednesday announced the initiation of two Phase 3 trials evaluating its drug candidate NB-001 as a topical treatment for cold sores, a step forward in its over-the-counter drug licensing agreement with GlaxoSmithKline Consumer Healthcare
Ann Arbor-based NanoBio Corp. said Tuesday that it had been awarded its seventh United States patent covering its novel nanoemulsion technology. The new claims encompass methods of treating Herpes Simplex I infections, including herpes labialis, […]
FDA hearings begin today over whether the diabetes medication Avandia raises the risk of heart attacks.